Frier Levitt

PBM audits flagging inventory shortfalls? It may not be what it looks like. Learn common causes and how pharmacies can respond. Read more: bit.ly/4vclaOn #PBM #PharmacyCompliance #HealthcareLaw #PharmacyLaw #FrierLevitt

Medicaid payment suspensions can bring operations to a standstill, often without a finding of fraud. Learn how Frier Levitt helped a provider secure relief, restore eligibility, and release held claims—and what it means for others facing enforcement. Read more: bit.ly/4bVnOz4 #Medicaid #HealthcareLaw #AuditDefense #FrierLevitt

Specialty pharmacies continue to face growing pressure from PBM reimbursement practices, audit activity, and enforcement risk. At the Asembia 2026 Specialty Pharmacy Summit, Partner Jesse Dresser will be meeting with industry stakeholders to help navigate PBM-related challenges, audit exposure, and reimbursement disputes. Jesse advises pharmacies on managing audit risk, responding to PBM actions, network terminations and addressing regulatory scrutiny impacting their business. If these challenges are impacting your organization, we’d welcome the conversation. Schedule a meeting by clicking here: bit.ly/4uAr5wh

Changing jobs with a noncompete? Transparency matters. New employers can help assess risk—but only if you disclose early. 🔗 Watch the full interview: bit.ly/4bJSmoK #HealthcareLaw #Noncompete #Physicians #EmploymentLaw #FrierLevitt

Attention ASCs and Anesthesia Providers! NJ’s COVID-era CRNA waivers expire on April 2, bringing back pre-pandemic supervision and compliance requirements. 🔗 Are your supervision models and agreements compliant? bit.ly/4sOuINO #HealthcareLaw #ASC #CRNA #Compliance #FrierLevitt

An OPM audit found $615M+ in PBM overcharges, under a “pass-through” contract. What does this mean for plan sponsors? Read more: bit.ly/3O6D6Jo #PBM #HealthcareLaw #PharmacyBenefits #FrierLevitt

DEA’s Operation Meltdown signals increased enforcement against illegal online pharmacies. What does it mean for compliant providers and pharmacies? 🔗 Read more: bit.ly/4bICAdC #DEA #HealthcareLaw #PharmacyCompliance #FrierLevitt

Washington’s new 340B law is already being challenged by major drugmakers. What does it mean for the future of 340B? Read more: bit.ly/4ce5nqD #340B #HealthcareLaw #Pharmacy #FrierLevitt

Today, we recognize National Doctors' Day and the physicians who show up every day to care for patients and make critical decisions under extraordinary pressure. At Frier Levitt, we see firsthand the regulatory, contractual, and business challenges physicians face beyond patient care - and we are proud to be in their corner as they navigate today's complex healthcare landscape. Thank you for all that you do. It's a privilege to advocate for you. #NationalDoctorsDay #HealthcareLaw #Physicians #Doctors #FrierLevitt #HealthcareProfessionals

Physicians: don’t sign a noncompete without understanding the risks. From evaluating enforceability to negotiating protections with a new employer, taking the right steps early can make all the difference. 🔗 Watch the full interview: bit.ly/4dfSkpP #HealthcareLaw #EmploymentLaw #Physicians #FrierLevitt

CMS has overhauled reimbursement for skin substitutes. Flat fee payments + no reimbursement for wastage = major impact on providers. Here’s what it means for compliance, audits, and revenue: bit.ly/4c8EKU2 #Medicare #HealthcareLaw #WoundCare #Reimbursement #FrierLevitt

340B manufacturer data demands are increasing. Learn how claim-level data requirements are impacting covered entities and pharmacies. 🔗 Read more: bit.ly/3NtaJ89 #340B #HealthcareLaw #Pharmacy #FrierLevitt

The specialty pharmacy landscape continues to face increasing pressure from PBM practices, reimbursement constraints, and network access barriers. At the Asembia 2026 Specialty Pharmacy Summit, Co-Founding Partner Jonathan Levitt will be meeting with pharmacies, manufacturers and industry stakeholders to address these challenges, including PBM reimbursement disputes, and network participation issues. With deep experience challenging PBM conduct through regulatory advocacy and litigation, Jon helps pharmacies identify discrepancies, enforce their rights, and pursue meaningful outcomes. If you’re attending and dealing with these issues, let’s connect. Click here to schedule a meeting with Jon: bit.ly/4uAr5wh

PBM audits are increasingly focusing on prior authorizations, and pharmacies are being scrutinized more closely than ever. Learn where pharmacies face risk and how to avoid recoupments and audit findings. Read more: bit.ly/40Z5xMf #HealthcareLaw #PBM #Pharmacy #FrierLevitt

Medicare payment suspensions are rising, and labs are a key target. Learn what triggers a suspension and how to respond to protect your revenue and operations. Read more: bit.ly/4c5KnCk #Medicare #HealthcareCompliance #Laboratories #AuditDefense #FrierLevitt

Physician noncompetes remain governed by state law, not federal rule. From enforceability to structuring agreements across multiple states, understanding the nuances is critical for healthcare organizations. Read more: bit.ly/4bI3l0t #HealthcareLaw #EmploymentLaw #NonCompete #FrierLevitt

DOJ secures $31M judgment in healthcare kickback case. From marketing arrangements to telehealth prescribing and copay practices, understanding where enforcement is focused is critical. 🔗 Read more: bit.ly/41s0BQ8 #HealthcareLaw #FCA #AKS #Telehealth #FrierLevitt

As we celebrate National Physicians Week (March 25–31), Frier Levitt proudly recognizes the physicians whose expertise, dedication, and compassion make a lasting impact on patients and communities every day. From delivering critical care to navigating an increasingly complex healthcare landscape, physicians play an essential role in advancing medicine and improving outcomes. We are honored to support physicians nationwide as they address the legal and regulatory challenges that come with practicing in today’s environment, so they can remain focused on providing high-quality care. Thank you to all physicians for the work you do and the difference you make. This week and every week. #PhysiciansWeek #HealthcareLaw #Doctors #HealthcareProfessionals #FrierLevitt

Peptide deregulation may be on the horizon, and companies are already moving. New reporting highlights growing market interest and regulatory uncertainty. 🔗 Read the full article with Financial Times (subscription required): bit.ly/4sommMA #HealthcareLaw #FDA #LifeSciences #FrierLevitt

Update: New Jersey is one step closer to expanding independent practice authority for Advanced Practice Nurses, but with important limitations. Key changes include higher experience requirements, narrower scope, and limits on aesthetic services. Learn what it means: bit.ly/4t11kU5 #HealthcareLaw #APN #NewJersey #FrierLevitt